PL367779A1 - Kompozycja substancji czynnych do lekowej terapiiuzależnienia od nikotyny - Google Patents

Kompozycja substancji czynnych do lekowej terapiiuzależnienia od nikotyny

Info

Publication number
PL367779A1
PL367779A1 PL02367779A PL36777902A PL367779A1 PL 367779 A1 PL367779 A1 PL 367779A1 PL 02367779 A PL02367779 A PL 02367779A PL 36777902 A PL36777902 A PL 36777902A PL 367779 A1 PL367779 A1 PL 367779A1
Authority
PL
Poland
Prior art keywords
active substance
substance combination
nicotine dependency
medicamentous therapy
medicamentous
Prior art date
Application number
PL02367779A
Other languages
English (en)
Inventor
Joachim Moormann
Hermann Mucke
Klaus Opitz
Original Assignee
Hf Arzneimittelforschung Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforschung Gmbh filed Critical Hf Arzneimittelforschung Gmbh
Publication of PL367779A1 publication Critical patent/PL367779A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL02367779A 2001-07-12 2002-07-05 Kompozycja substancji czynnych do lekowej terapiiuzależnienia od nikotyny PL367779A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10134038A DE10134038A1 (de) 2001-07-12 2001-07-12 Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
PCT/EP2002/007477 WO2003007966A1 (de) 2001-07-12 2002-07-05 Wirkstoff-kombination zur medikamentösen therapie der nikotinabhängigkeit

Publications (1)

Publication Number Publication Date
PL367779A1 true PL367779A1 (pl) 2005-03-07

Family

ID=7691630

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02367779A PL367779A1 (pl) 2001-07-12 2002-07-05 Kompozycja substancji czynnych do lekowej terapiiuzależnienia od nikotyny

Country Status (27)

Country Link
US (1) US20040167145A1 (pl)
EP (1) EP1404341B1 (pl)
JP (1) JP2005502633A (pl)
KR (1) KR20040013143A (pl)
CN (1) CN1527712A (pl)
AR (1) AR034767A1 (pl)
AT (1) ATE340576T1 (pl)
AU (1) AU2002354856B2 (pl)
BR (1) BR0211323A (pl)
CA (1) CA2452432C (pl)
CZ (1) CZ301204B6 (pl)
DE (2) DE10134038A1 (pl)
DK (1) DK1404341T3 (pl)
EA (1) EA007628B1 (pl)
ES (1) ES2274064T3 (pl)
HU (1) HUP0401013A3 (pl)
IL (2) IL159789A0 (pl)
MX (1) MXPA04000344A (pl)
MY (1) MY131858A (pl)
NO (1) NO20040119L (pl)
NZ (1) NZ530512A (pl)
PL (1) PL367779A1 (pl)
PT (1) PT1404341E (pl)
SK (1) SK112004A3 (pl)
UA (1) UA79752C2 (pl)
WO (1) WO2003007966A1 (pl)
ZA (1) ZA200400305B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10338544B4 (de) * 2003-08-19 2017-08-31 Janssen Pharmaceutica N.V. Buccale Formulierungen des Galanthamins und deren Anwendungen
DE10354893B4 (de) * 2003-11-24 2011-03-10 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
CL2008003507A1 (es) 2007-11-26 2009-11-27 Neuroderm Ltd Composicion farmaceutica que comprende nicotina y un inhibidor de la desensibilizacion del receptor de acetilcolina nicotinico (nachr) opipramol; kit farmaceutico; dispositivo medico; y uso para tratar una enfermedad o trastorno del sistema nervioso central o periferico.
DE102007058504A1 (de) * 2007-12-05 2009-07-09 Acino Ag Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
DE3843239C1 (pl) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
US5519017A (en) * 1990-03-29 1996-05-21 Lts Lohmann Therapie-Systeme Gmbh + Co. Kg Pharmaceutic formulation for the treatment of alcoholism
DE4010079A1 (de) * 1990-03-29 1991-10-02 Lohmann Therapie Syst Lts Pharmazeutische formulierung zur behandlung des alkoholismus
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
DE4301782C1 (de) * 1993-01-23 1994-08-25 Lohmann Therapie Syst Lts Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit
PL184590B1 (pl) * 1994-10-21 2002-11-29 Sanochemia Pharmazeutika Ag Sposób wytwarzania pochodnych a heksahydro H benzofuro[ a ef][ ] benzoazepiny sposób odbromowania tych pochodnych sposób wytwarzania związków typu N demetylobromo i epibromo galantaminy oraz nowe związki z określonego zbioru
DE19509663A1 (de) * 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
GB9514821D0 (en) * 1995-07-19 1995-09-20 Sod Conseils Rech Applic Galanthamine derivatives
WO1997018781A1 (en) * 1995-11-20 1997-05-29 University Of Miami Method of treating nicotine dependence
CA2220768A1 (en) * 1996-03-13 1997-09-18 Yale University Smoking cessation treatments using naltrexone and related compounds
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US5965567A (en) * 1997-07-15 1999-10-12 Albany Medical College Method for treating nicotine addiction
OA11740A (en) * 1998-12-24 2005-05-13 Janssen Pharmaceutica Nv Controlled release galantamine composition.
DE19906979B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
CA2380810C (en) * 1999-08-13 2006-03-14 Southern Research Institute Pyridomorphinans and use thereof
MXPA02005667A (es) * 1999-12-10 2004-09-10 Bonnie Davis Analogos de galantamina y licoramina como moduladores de los receptores nicotinicos.
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie

Also Published As

Publication number Publication date
JP2005502633A (ja) 2005-01-27
MXPA04000344A (es) 2004-05-04
IL159789A0 (en) 2004-06-20
CA2452432A1 (en) 2003-01-30
AU2002354856B2 (en) 2007-05-31
ATE340576T1 (de) 2006-10-15
WO2003007966A1 (de) 2003-01-30
HK1063159A1 (en) 2004-12-17
US20040167145A1 (en) 2004-08-26
HUP0401013A2 (hu) 2004-08-30
SK112004A3 (en) 2004-06-08
CN1527712A (zh) 2004-09-08
EP1404341B1 (de) 2006-09-27
CZ200419A3 (cs) 2004-05-12
UA79752C2 (en) 2007-07-25
NO20040119L (no) 2004-01-30
DK1404341T3 (da) 2007-02-05
IL159789A (en) 2008-07-08
CA2452432C (en) 2009-09-01
NZ530512A (en) 2007-09-28
BR0211323A (pt) 2004-11-30
CZ301204B6 (cs) 2009-12-09
HUP0401013A3 (en) 2011-03-28
EA007628B1 (ru) 2006-12-29
EP1404341A1 (de) 2004-04-07
DE10134038A1 (de) 2003-02-06
PT1404341E (pt) 2007-01-31
AR034767A1 (es) 2004-03-17
ZA200400305B (en) 2004-05-24
DE50208267D1 (de) 2006-11-09
EA200400116A1 (ru) 2004-08-26
ES2274064T3 (es) 2007-05-16
KR20040013143A (ko) 2004-02-11
MY131858A (en) 2007-09-28

Similar Documents

Publication Publication Date Title
EP1416884A4 (en) DISTRIBUTION OF AGENTS WITH THERAPEUTIC PROPERTIES
HUP0200819A3 (en) Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2003297621A8 (en) Medical devices for delivery of therapeutic agents
EP1165048A4 (en) COMPOSITIONS AND METHOD FOR IMPROVED ADMINISTRATION OF IONIZABLE HYDROPHOLE THERAPEUTIC SUBSTANCES
EP1448150A4 (en) TREATMENT OF HYPERPROLIFERATIVE DISEASES AND ACTIVE VITAMIN D ANALOGUE
HUP0303311A3 (en) Highly flexible transdermal therapeutic system having nicotine as active substance
EP1077704A4 (en) COMBINATION THERAPY FOR TREATING DEPRESSION
ID26861A (id) Terapi gabungan untuk pengobatan depresi refaktori
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2002308289A1 (en) Highly flexible transdermal therapeutic system having nicotine as active substance
PL366212A1 (pl) Preparaty zawierające lek glukokortykoidowy do leczenia chorób oskrzelowo-płucnych
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
AU5937901A (en) Combination therapy of respiratory diseases using antibodies
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
PL367779A1 (pl) Kompozycja substancji czynnych do lekowej terapiiuzależnienia od nikotyny
NO20014812L (no) Fremgangsmate for tilveiebringelse av kosmetisk/medisinsk terapi
GB0111594D0 (en) Pipecolnic acid derivatives method of manufacturing the same and therapeutic agents containing these compounds
AU2002354856A1 (en) Active substance combination for medicamentous therapy of nicotine dependency
SI1404341T1 (sl) Kombinacija aktivnih snovi za medikamentno terapijo nikotinske odvisnosti
IL155819A0 (en) Methods of treatment comprising administration of substance p
ID24922A (id) Terapi kombinasi untuk pengobatan aids
GB9906808D0 (en) Formulation for treatment of pain
AU2002351798A1 (en) Methods and dosage forms for improving the bioavailability of therapeutic agents

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)